Rifaximin for Chronic Immune Activation in People With HIV
Clinical trial NCT01866826 · COMPLETED
Trial details
- NCT number
- NCT01866826
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-18
- Primary completion
- 2016-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.